HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martini, N. Articles by Rusch, V. W. Search for Related Content PubMed PubMed Citation Articles by Martini, N. Articles by Rusch, V. W.

The Annals of Thoracic Surgery, Vol 58, 1447-1451, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Management of non-small cell lung cancer with direct mediastinal involvement

N Martini, A Yellin, RJ Ginsberg, MS Bains, ME Burt, PM McCormack and VW Rusch
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

The results of surgical treatment were analyzed for 102 patients with non-small cell lung cancer invading the mediastinum by direct extension (T3 and T4), but those who had N2 disease were excluded to eliminate the adverse prognostic effect of this nodal subset. The histologic type was squamous cell carcinoma in 55 patients, adenocarcinoma in 40, and large cell carcinoma in 7. There were 58 T3 tumors invading the mediastinal pleura or fat, phrenic nerve, vagus nerve, pericardium, or pulmonary vessels and 44 T4 lesions invading the aorta, vena cava, esophagus, trachea, spine, or atrium. Resection included lobectomy (33 patients), pneumonectomy (32 patients), and limited resection (6 patients). Complete resection was possible in 46 patients and incomplete or no resection was possible in 56. The interstitial implantation of radioactive sources to control residual tumor also was undertaken in 43 patients. The operative mortality was 6%. The overall survival (Kaplan-Meier) was 19% at 5 years (median survival time, 18 months). Factors found to be significantly affect survival were complete resectability and the histologic type. With complete resection, the 5-year survival was 30% (p = 0.005). The 5-year survival in patients with adenocarcinoma or large-cell carcinoma was 30%, compared with 14% in patients with squamous cell carcinoma (p = 0.002). The extent of mediastinal involvement (T3 versus T4) influenced resectability and survival, and this approached statistical significance (p = 0.055). We conclude that most patients with non-small cell carcinoma and mediastinal invasion do poorly with primary surgical treatment.

This article has been cited by other articles:

				B. Yildizeli, P. G. Dartevelle, E. Fadel, S. Mussot, and A. Chapelier Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Ann. Thorac. Surg., October 1, 2008; 86(4): 1065 - 1075. [Abstract] [Full Text] [PDF]

				Y. Sekine, K. Yasufuku, S. Motohashi, and T. Fujisawa Triple reconstruction of pulmonary artery, superior vena cava and bronchus for lung cancer Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 509 - 510. [Abstract] [Full Text] [PDF]

				K. Wiebe, H. Baraki, P. Macchiarini, and A. Haverich Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 571 - 577. [Abstract] [Full Text] [PDF]

				M. de Perrot, E. Fadel, S. Mussot, A. de Palma, A. Chapelier, and P. Dartevelle Resection of Locally Advanced (T4) Non-Small Cell Lung Cancer With Cardiopulmonary Bypass Ann. Thorac. Surg., May 1, 2005; 79(5): 1691 - 1696. [Abstract] [Full Text] [PDF]

				B. J. Park, M. Bacchetta, M. S. Bains, R. J. Downey, R. Flores, V. W. Rusch, and L. N. Girardi Surgical management of thoracic malignancies invading the heart or great vessels Ann. Thorac. Surg., September 1, 2004; 78(3): 1024 - 1030. [Abstract] [Full Text] [PDF]

				G. B. Ratto, R. Costa, G. Vassallo, A. Alloisio, P. Maineri, and P. Bruzzi Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer Ann. Thorac. Surg., July 1, 2004; 78(1): 234 - 237. [Abstract] [Full Text] [PDF]

				C. C.M. Pitz, A. B. de la Riviere, H. A. van Swieten, C. J.J. Westermann, J.-W. J. Lammers, and J. M.M. van den Bosch Results of surgical treatment of T4 non-small cell lung cancer Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1013 - 1018. [Abstract] [Full Text] [PDF]

				T. Osaki, K. Sugio, T. Hanagiri, M. Takenoyama, T. Yamashita, M. Sugaya, M. Yasuda, and K. Yasumoto Survival and prognostic factors of surgically resected T4 non-small cell lung cancer Ann. Thorac. Surg., June 1, 2003; 75(6): 1745 - 1751. [Abstract] [Full Text] [PDF]

				W. J. Scott, J. Howington, and B. Movsas Treatment of Stage II Non-small Cell Lung Cancer Chest, January 1, 2003; 123(1_suppl): 188S - 201S. [Abstract] [Full Text] [PDF]

				M. Riquet, L. Lang-Lazdunski, F. Le Pimpec-Barthes, A. Dujon, R. Souilamas, C. Danel, and D. Manac'h Characteristics and prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., January 1, 2002; 73(1): 253 - 258. [Abstract] [Full Text] [PDF]

				C. Doddoli, G. Rollet, P. Thomas, O. Ghez, Y. Seree, R. Giudicelli, and P. Fuentes Is lung cancer surgery justified in patients with direct mediastinal invasion? Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 339 - 343. [Abstract] [Full Text] [PDF]

				A. Bernard, O. Bouchot, O. Hagry, and J. P. Favre Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 344 - 349. [Abstract] [Full Text] [PDF]

				S. Roychowdhury, L. A. Loevner, D. M. Yousem, A. Chalian, and K. T. Montone MR Imaging for Predicting Neoplastic Invasion of the Cervical Esophagus AJNR Am. J. Neuroradiol., October 1, 2000; 21(9): 1681 - 1687. [Abstract] [Full Text]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052. [Abstract] [Full Text] [PDF]

				E. van Velzen, A. Brutel de la Riviere, H. J.J. Elbers, J.-W. J. Lammers, and J. M.M. van den Bosch Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma Ann. Thorac. Surg., April 1, 1999; 67(4): 903 - 907. [Abstract] [Full Text] [PDF]

				M. Ernst, M. Koller, R. Grobholz, and R. Moosdorf Both atrial resection and superior vena cava replacement in sleeve pneumonectomy for advanced lung cancer Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 530 - 532. [Abstract] [Full Text] [PDF]

				E. A. Rendina, F. Venuta, T. D. Giacomo, A. M. Ciccone, G. Ruvolo, G. F. Coloni, C. Ricci, and S. G. A. Patterson INDUCTION CHEMOTHERAPY FOR T4 CENTRALLY LOCATED NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 225 - 233. [Abstract] [Full Text] [PDF]

				S. S. Leong, C. M. Rocha Lima, C. A. Sherman, and M. R. Green The 1997 International Staging System for Non-Small Cell Lung Cancer: Have All the Issues Been Addressed? Chest, January 1, 1999; 115(1): 242 - 248. [Abstract] [Full Text] [PDF]

				K. Inoue, M. Sato, S. Fujimura, A. Sakurada, S. Takahashi, K. Usuda, T. Kondo, T. Tanita, M. Handa, Y. Saito, et al. Prognostic assessment of 1310 patients with non-small-cell lungcancer who underwent complete resection from 1980 to 1993 J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 407 - 411. [Abstract] [Full Text]

				C. C. M. Pitz, A. B. de la Riviere, H. R. J. Elbers, C. J. J. Westermann, and J. M. van den Bosch Results of Resection of T3 Non-Small Cell Lung Cancer Invading the Mediastinum or Main Bronchus Ann. Thorac. Surg., October 1, 1996; 62(4): 1016 - 1020. [Abstract] [Full Text]